NASDAQ · NGNEHealthcarePharmaceuticals

Neurogene news

$28.39−0.32%
Close Sep 29, 2026 · split-adjusted
Articles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0

About Neurogene

No recent articles focused on Neurogene.

Also mentions NGNE

Articles that tag NGNE but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology